Business Standard

Thyrocare rallies 10%, hits record high on expectation of strong Q2 results

Earlier this month, the company reported nearly 37 per cent year-on-year and over 100 per cent sequential growth in aggregate revenue for Q2FY21

coronavirus
Premium

A medical staffer holds the hand of a patient, in the ICU of the Bassini Hospital, in Cinisello Balsamo, near Milan, Italy, Tuesday, April 14, 2020 | Photo: AP/PTI

SI Reporter Mumbai
Shares of Thyrocare Technologies rallied 10 per cent to hit a record high of Rs 1,163 on the BSE in intra-day trade on Monday on expectation of strong July-September quarter (Q2FY21) earnings. The stock of the diagnostic company surpassed its previous high of Rs 1,150 touched on October 12, 2020.

At 11:37 am, Thyrocare Technologies was trading 6 per cent higher at Rs 1,121, as compared to 0.60 per cent decline in the S&P BSE Sensex. Trading volumes on the counter doubled with a combined 920,000 equity shares changing hands on the NSE and BSE till the time of writing of

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in